In 2006, WHO set forth its vision for a public health approach to delivering antiretroviral
therapy. This approach has been broadly adopted in resource-poor settings and has …

Background Isoniazid preventive therapy prevents active tuberculosis in people with HIV,
but previous studies have found no evidence of benefit in people with HIV who had a …

Abstract Effect estimates from randomized trials and observational studies might not be
directly comparable because of differences in study design, other than randomization, and in …

The availability of and increased access to antiretroviral therapy (ART) has significantly
reduced the morbidity and mortality associated with HIV. As a result, perinatally infected …

Abstract HIV Self-Testing (HIVST) aims to increase HIV testing coverage and can facilitate
reaching the UNAIDS 90-90-90 targets. In Senegal, key populations bear a disproportionate …

Background: HIV viral load suppression (VLS) is the most important indicator of successful
antiretroviral therapy. In 2016, Bulambuli District started monitoring HIV patients on ART …

Background. Many people living with HIV in South Africa (SA) are not aware of their
seropositive status and are diagnosed late during the course of HIV infection. These …

Background Recommendations have differed nationally and internationally with respect to
the best time to start antiretroviral therapy (ART). We compared effectiveness of three …

Study objective Newer combination HIV antigen-antibody tests allow detection of HIV sooner
after infection than previous antibody-only immunoassays because, in addition to HIV-1 and …

WHO first published guidelines on the use of antiretroviral therapy (ART) for HIV infection
among adults and adolescents in 2002 (1) and on the use of antiretroviral (ARV) drugs for …